Staging symptoms of bladder cancer?

Update Date: Source: Network

summary

The staging and grading of bladder cancer may involve more content and space, but the staging and grading of bladder cancer is of great significance to the planning of treatment plan for patients with bladder cancer, and has a clear indication for patients and their families to recognize the severity of the disease. Please read the staging symptoms of bladder cancer carefully?.

Staging symptoms of bladder cancer?

Bladder cancer includes urothelial cell carcinoma, squamous cell carcinoma and adenocarcinoma, followed by rare metastatic carcinoma, small cell carcinoma and carcinosarcoma. Bladder urothelial carcinoma is the most common, accounting for more than 90% of bladder cancer. Squamous cell carcinoma of bladder accounted for 3-7%, adenocarcinoma accounted for less than 2%. Usually, the staging and grading of bladder cancer refer to "bladder urothelial cell carcinoma".

The so-called staging, popularly speaking, is early and late. It's the time after the tumor develops and the lesion lasts. The longer the time is, the more advanced the cancer cells are; The earlier the time is, the less invasive the cancer cells are. At the same time, the early stage tumors generally have a high degree of differentiation and belong to low grade; However, in advanced stage, the degree of cell differentiation is low, which belongs to high grade.

The stage of bladder transitional cell carcinoma mainly refers to the degree of invasion and metastasis, which is an important index to judge the prognosis of bladder cancer. The correlation between clinical stage and prognosis of bladder cancer is stronger than that of bladder cancer grade, which is the most valuable parameter to judge the prognosis of bladder cancer. The TNM staging method of the 6th edition of UICC (2002) is widely used in the world.

matters needing attention

High grade, multiple and advanced bladder cancer is easy to recur after operation. Shengyu Jiedu Capsule can be taken at the same time of postoperative perfusion to reduce the recurrence rate and achieve the purpose of clinical cure.